Work in progress: transcatheter management of primary carcinoma of the liver.
Twenty-four patients with hepatocellular carcinoma or cholangiocarcinoma were treated with hepatic artery infusion (HAI) of chemotherapeutic agents (14 patients) or hepatic artery embolization (HAE) (11 patients). One patient had a combination of the two treatments. Ten of the 14 (71%) patients who underwent HAI demonstrated partial remission. The median survival time was 12.3 months. Six of the 9 patients (67%) who underwent HAE and for whom follow-up was available responded to treatment. The median survival time for those patients was 17.4 months.
D002759:Adenoma, Bile Duct / Q000628:therapy*; D000328:Adult; D000368:Aged; D000970:Antineoplastic Agents / Q000008:administration & dosage*; D006528:Carcinoma, Hepatocellular / Q000000981:diagnostic imaging / Q000188:drug therapy / Q000628:therapy*; D002404:Catheterization / Q000379:methods; D004621:Embolization, Therapeutic; D005260:Female; D006499:Hepatic Artery; D006801:Humans; D007261:Infusions, Intra-Arterial; D008113:Liver Neoplasms / Q000000981:diagnostic imaging / Q000188:drug therapy / Q000628:therapy*; D008297:Male; D008875:Middle Aged; D011859:Radiography
D000970:Antineoplastic Agents